Glytec

Introducing Glytec’s CMS Reporting CareKit – Your Essential Guide for Navigating the CMS IPPS Mandate! The countdown has begun for the new CMS rulemaking, and the clock is ticking for hospitals to prepare for the reporting of Severe Hyperglycemia and Hypoglycemia eCQMs. Starting January 2026, compliance with the CMS IPPS Mandate will be mandatory, and if you haven’t started planning or budgeting for these critical changes, now is the time. Glytec’s CMS Reporting CareKit – Your roadmap to success! Our comprehensive CareKit equips hospitals and health systems with the tools, insights, and guidance needed to navigate this critical transition. Here’s what’s inside: Summary of CMS Ruling: An actionable overview designed to empower your Endocrinologists and Diabetes Educators while ensuring your executive teams understand the importance of compliance. Implementation Timeline: A step-by-step guide developed by our experts to keep your organization on track, ensuring timely and smooth implementation. CMS Checklist: Tailored to your needs, this detailed checklist will help you cover all critical steps required for compliance, ensuring nothing is overlooked. Next Steps: Let’s partner in advancing diabetes care excellence and ensuring your hospital is prepared. Visit glytec.com to request your Glytec CMS Reporting CareKit and schedule a meeting with us. [email protected] (864) 370-3297 #CMSMandate #DiabetesCare #HospitalCompliance #eCQMs #Glytec

We are thrilled to share that our Chief Medical Officer, Jordan Messler, MD, SFHM, FACP, has co-authored a groundbreaking letter regarding the recent Centers for Medicare & Medicaid Services (CMS) mandate to report hospital harm measures for hypoglycemia and hyperglycemia starting in 2026. This piece addresses the importance of comprehensive glycemia management, the risks of focusing on a single measure, and the need for hospital readiness to implement these changes effectively. Dr. Messler’s expertise and leadership at Glytec and in the field are invaluable as we continue to innovate to bridge the glycemic management gap. Check out the full letter here: https://lnkd.in/eZRnuGcm Join me in congratulating Dr. Messler for this significant contribution to the medical community, as well as his commitment to advancing and improving inpatient diabetes and insulin management across the healthcare continuum. #DiabetesManagement #InsulinManagement #HealthcareInnovation #Leadership #CMS #PatientCare

We’re thrilled to share that Glytec has partnered with Ardent Health to enhance diabetes and insulin management across their network of hospitals and clinics! This collaboration will leverage Glytec’s innovative technology to improve patient safety, outcomes, and the overall quality of care for the millions affected by diabetes. As Brad Hoyt, MD, from Ardent emphasizes, our shared commitment to providing exceptional care is more crucial than ever. Key benefits include: - Improved Patient Outcomes: Data-driven algorithms optimize insulin therapy, reducing complications and length of hospital stays. - Streamlined Workflow: Enhanced clinical efficiency for healthcare professionals. - Lower Costs of Care: Decreased risk of adverse events leads to cost savings in diabetes management. We’re excited to roll out our technology across Ardent locations and look forward to making a meaningful impact together. Read press release: https://lnkd.in/eHMgZZDF #Glytec #ArdentHealth #DiabetesManagement #InsulinManagement #HealthcareInnovation #PatientSafety #Partnerships #ClinicalEfficiency

The American Diabetes Association (ADA) and The The Leapfrog Group have partnered to launch the first-ever national designation program that recognizes hospitals demonstrating a strong commitment to the safety and well-being of inpatients who are living with #diabetes. Learn more: https://bit.ly/442TtZv We are proud members of The Leapfrog Group Partners Advisory Committee (PAC).

Don't take our word for it. Our customers say it best. Grady Health System is creating efficiencies and reducing risk in diabetes and insulin management. Visit https://lnkd.in/eT6RnkZV for more information. #DiabetesManagement #PatientSafety #InsulinManagement #ClinicalExcellence

Driving outcomes, revenue and cost savings through excellence in diabetes and insulin management. Visit https://lnkd.in/eT6RnkZV for more information. #DiabetesManagement #PatientSafety #InsulinManagement #ClinicalExcellence

Why hundreds of hospital executives and clinical providers rely on Glytec to save time, reduce costs and improve patient outcomes. Visit https://lnkd.in/eT6RnkZV for more information. #DiabetesManagement #PatientSafety #InsulinManagement #ClinicalExcellence

Glytec Expands Global Collaboration with Roche to Revolutionize Hospital Diabetes Management Glytec is excited to announce the expansion of our global collaboration with Roche, a leader in pharmaceuticals and diagnostics, to revolutionize hospital diabetes management. This collaboration will integrate Glytec’s software with Roche’s cobas® pulse, a smart-device hospital blood glucose system, across the U.S. and other global markets. “Diabetes knows no borders, profoundly impacting hospital diabetes management and patient outcomes worldwide,” said Robby Booth, Co-founder and Chief Strategy Officer at Glytec. We are proud of our expanded collaboration with Roche, which reaffirms our commitment to addressing this critical healthcare challenge for patients, providers, and payors and positively impacting lives worldwide.” As hospitals prepare for the upcoming CMS mandate on severe hypoglycemia and hyperglycemia reporting, this collaboration ensures they have the tools needed to improve patient safety and meet regulatory requirements. Press Release: https://lnkd.in/dCkantgg #DiabetesManagement #PatientSafety #Glytec #Roche #HospitalCare #CMSMandate #GlobalCollaboration #InsulinManagement #ClinicalExcellence

Glytec Expands Global Collaboration with Roche to Revolutionize Hospital Diabetes Management Glytec is excited to announce the expansion of our global collaboration with Roche, a leader in pharmaceuticals and diagnostics, to revolutionize hospital diabetes management. This collaboration will integrate Glytec’s software with Roche’s cobas® pulse, a smart-device hospital blood glucose system, across the U.S. and other global markets. “Diabetes knows no borders, profoundly impacting hospital diabetes management and patient outcomes worldwide,” said Robby Booth, Co-founder and Chief Strategy Officer at Glytec. We are proud of our expanded collaboration with Roche, which reaffirms our commitment to addressing this critical healthcare challenge for patients, providers, and payors and positively impacting lives worldwide.” As hospitals prepare for the upcoming CMS mandate on severe hypoglycemia and hyperglycemia reporting, this collaboration ensures they have the tools needed to improve patient safety and meet regulatory requirements. Press Release: https://lnkd.in/dCkantgg #DiabetesManagement #PatientSafety #Glytec #Roche #HospitalCare #CMSMandate #GlobalCollaboration #InsulinManagement #ClinicalExcellence

Having an amazing time at the Association of Diabetes Care & Education Specialists conference 2024. Stop by booth #247 and meet our team Kyle Caple Robby Booth Betsy Kubacka DNP, MSN, RN, AGPCNP-BC, RDN, CDCES Jonda Dawson Michael C. Piro, MBA Michael Dunn and Andrew Schwier. Let us show you how Glytec can help your organization!